Trial Search Results
Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant
The purpose of the proposed research study is to evaluate whether bone marrow transplant patients prefer the Stanford letter advance care planning tool to the standard Advance directive.
Completion of advance care planning prior to BMT is very important, but not often done. The investigators believe that the Stanford Letter will be preferred by patients and will allow them to feel more comfortable and share more of their wishes with family members and the medical team.
Stanford is currently not accepting patients for this trial.
- Other: Stanford Letter
- Other: Interview
- Other: Questionnaire Administration
- Other: CA Advance Health Care Directive Form
- All BMT patients at Stanford who are adults and give consent
- Less than 18 years of age
Ages Eligible for Study
18 Years - 100 Years
Genders Eligible for Study